Data / Form D filings / Ora Biomedical, Inc.
Ora Biomedical, Inc.: Form D filings
Ora Biomedical, Inc., a biotechnology company in Tukwila, WA, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on January 26, 2024, reports $720,000 sold of a $1 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12101 Tukwila International Blvd, Suite 210, Tukwila, WA, 98168
- Phone
- (206) 839-6250
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1927878
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | New notice | $1,020,000 | $720,000 | $300,000 | 6 | Jan 19, 2024 | sec.gov |
| Jun 13, 2022 | New notice | $750,000 | $100,000 | $650,000 | 1 | Jun 9, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Sabey | Director | |
| Mitchell Lee | Executive Officer, Director, Promoter | |
| Matthew Kaeberlein | Director, Promoter |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Jan 22, 2024 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ora Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.